{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences","slug":"video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences","published_at":"2025-10-28T09:54:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2174119/c1e-x878rs9g961sxnj8r9-dmxxggonh6nr-qul8n0.mp4","summary":"What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences. We’ll be covering a myriad of biotech topics, from “business athletes” to the role of the operating company in the drug development industry. We’ll also be premiering our lightning round - quick questions and inspired answers from our podcast guests. Okay, let’s start the podcast!","meta_description":"What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3676,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-63-bruce-leuchter-md-president-and-ceo-of-neurvati-neurosciences.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}